Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BKR vs GSK✓SelectedUSD · GSKBKR vs GSK performance historyLatest closeAs of-3.99%11/20
Stock and ETF performance explorer

BKR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+121.4%
GSK return
+40.7%
Excess return
+80.7%
Maximum drawdown
-46.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-0.1%-3.9%-4.0%
7D-9.4%-5.3%-4.0%-8.8%
30D-19.6%-3.7%-15.9%-19.3%
3M-28.3%-7.3%-21.0%-27.7%
6M-32.3%-4.2%-28.1%-32.1%
YTD-0.1%+0.9%-0.9%-0.8%
1Y-5.3%+7.3%-12.6%-6.8%
3Y+40.8%+52.7%-11.9%+28.9%
All+121.4%+40.7%+80.7%+87.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling